Video Experimental Relacionado
Updated: Jun 29, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
332
Ácido nucleico esférico de núcleo enzimático que permite una mejor respuesta inmune de cuproptosis y antitumoral a
Yuting Huang1, Xueliang Liu1, Jiawei Zhu1
1Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai 200240, China.
Journal of the American Chemical Society
|March 29, 2024
Resumen
Este estudio introduce una nanoplataforma que mejora la muerte celular inducida por el cobre (cuproptosis) al aumentar los niveles de oxígeno del tumor. Este enfoque aumenta las respuestas inmunes contra el cáncer y promueve la inmunidad a largo plazo.
Área de la Ciencia:
- Ingeniería biomédica
- Nanotecnología
- Inmunología del cáncer
Sus antecedentes:
- La cuproptosis, una muerte celular dependiente del cobre, activa las respuestas inmunes, pero es obstaculizada por el microambiente del tumor hipóxico.
- La hipoxia suprime la inmunidad antitumoral y la sensibilidad a la cuproposis, limitando la eficacia terapéutica.
Objetivo del estudio:
- Desarrollar una nano-plataforma que entregue iones de cobre para inducir la cuproptosis y superar la hipoxia del tumor.
- Mejorar la inmunidad antitumoral sensibilizando la cuproptosis y aliviando el microambiente inmunosupresor del tumor.
Principales métodos:
- Catalasa funcionalizada (CAT) con secuencias de ADN que contienen CpG a través de la amplificación de círculo rodante (RCA) para crear nanoplazas CAT-ecSNA-Cu.
- Utilizó CAT para convertir H2O2 en O2, mejorando la respiración mitocondrial y sensibilizando la cuproptosis.
- Se investigó el impacto del aumento de la oxigenación en el factor inducible por hipoxia-1 (HIF-1) y la activación de las células inmunes.
Principales resultados:
- La nanoplataforma CAT-ecSNA-Cu suministró con éxito iones de cobre, sensibilizó la cuproptosis y aumentó la oxigenación del tumor.
- El alivio de la hipoxia tumoral suprimió la expresión de HIF-1, reduciendo el microambiente inmunosupresor del tumor.
- La cuproptosis indujo la muerte celular inmunogénica (ICD), promoviendo la maduración de las células dendríticas (DC) y la presentación de antígenos a través de la activación de TLR9.
- La cuproptosis combinada con bloqueadores del punto de control (αPD-L1) mejoró la inmunidad antitumoral mediante la regulación al alza de PD-L1.
Conclusiones:
- La nanoplataforma desarrollada mejora efectivamente las respuestas inmunes antitumorales mediadas por la cuproposis al superar la hipoxia.
- Esta estrategia promueve la activación y la proliferación de las células T efectoras, lo que lleva a una inmunidad anticancerosa a largo plazo.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
01:27Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K